Adams Respiratory Therapeutics, Inc.·4

Jan 3, 4:01 PM ET

Adams Respiratory Therapeutics, Inc. 4

4 · Adams Respiratory Therapeutics, Inc. · Filed Jan 3, 2008

Insider Transaction Report

Form 4
Period: 2008-01-02
Valentino Michael J
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2008-01-02$0.40/sh+70,000$28,00070,000 total
  • Sale

    Common Stock

    2008-01-02$59.64/sh12,300$733,57257,700 total
  • Sale

    Common Stock

    2008-01-02$59.68/sh4,800$286,4641,432 total
  • Sale

    Common Stock

    2008-01-02$59.67/sh8,012$478,0766,232 total
  • Sale

    Common Stock

    2008-01-02$59.71/sh32$1,9110 total
  • Sale

    Common Stock

    2008-01-02$59.66/sh10,081$601,43214,244 total
  • Sale

    Common Stock

    2008-01-02$59.65/sh33,375$1,990,81924,325 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2008-01-0270,000512,745 total
    Exercise: $0.40Exp: 2013-08-11Common Stock (70,000 underlying)
  • Sale

    Common Stock

    2008-01-02$59.69/sh700$41,783732 total
Footnotes (2)
  • [F1]The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2006.
  • [F2]20% of the options vested on August 11, 2003, and the remainder of the options vest in prorata monthly installments over four years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION